HF
ZBH icon

Hoxton Financial’s Zimmer Biomet ZBH Stock Holding History

Hoxton Financial’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-324
Closed -$29K – 596
2013
Q4 		$29K Buy
+324
New +$28K 0.01% 282
2013
Q3 		– Sell
-267
Closed -$19K – 625
2013
Q2 		$19K Buy
+267
New +$20K 0.01% 293

Other funds holding ZBH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Hoxton Financial's ZBH Position: Q1 2014 in Review

Hoxton Financial sold out of Zimmer Biomet (ZBH) in Q1 2014, closing a stake of 324 shares — an estimated $29K sold.

Hoxton Financial first reported a position in ZBH in Q2 2013 and held it in 2 quarters. The position peaked at $29K in Q4 2013. 706 funds tracked by Wall St. Rank hold ZBH as of Q1 2014.

  • Hoxton Financial reported no remaining Zimmer Biomet position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 324 Zimmer Biomet shares in Q1 2014, an estimated $29K.
  • Hoxton Financial first reported a position in Zimmer Biomet in Q2 2013 and held it in 2 quarters.
  • Hoxton Financial's Zimmer Biomet position peaked at $29K in Q4 2013.
  • 706 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.